Guardant Health's Series E Round

Guardant Health raised a round of funding on May 11, 2017.

Guardant Health has developed genomic cancer testing from a single blood draw, helping oncologists learn information about patients while avoiding the costs and risks of tissue biopsies. The genomic t…

Articles about Guardant Health's Series E Round: